EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 66 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,930,343 | -8.2% | 3,370,506 | 0.0% | 0.53% | -4.3% |
| Q2 2023 | $29,323,402 | +195.9% | 3,370,506 | 0.0% | 0.55% | +147.3% |
| Q1 2023 | $9,909,288 | -16.0% | 3,370,506 | 0.0% | 0.22% | -6.3% |
| Q4 2022 | $11,796,771 | -55.8% | 3,370,506 | 0.0% | 0.24% | -58.0% |
| Q3 2022 | $26,660,000 | +0.5% | 3,370,506 | 0.0% | 0.57% | -19.5% |
| Q2 2022 | $26,526,000 | -35.2% | 3,370,506 | 0.0% | 0.71% | -20.9% |
| Q1 2022 | $40,952,000 | -0.7% | 3,370,506 | 0.0% | 0.89% | +23.0% |
| Q4 2021 | $41,255,000 | +79.1% | 3,370,506 | +52.5% | 0.73% | +127.9% |
| Q3 2021 | $23,033,000 | +105.0% | 2,210,506 | +76.8% | 0.32% | +77.2% |
| Q2 2021 | $11,238,000 | -11.5% | 1,250,000 | 0.0% | 0.18% | -6.2% |
| Q1 2021 | $12,700,000 | – | 1,250,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,190,921 | $50,920,000 | 12.31% |
| ACUTA CAPITAL PARTNERS, LLC | 307,944 | $3,742,000 | 1.75% |
| Samsara BioCapital, LLC | 480,000 | $5,832,000 | 1.47% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,909,407 | $35,349,000 | 1.08% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,666 | $2,256,000 | 0.93% |
| Altium Capital Management LP | 224,541 | $2,728,000 | 0.91% |
| RA Capital Management | 3,370,506 | $40,952,000 | 0.89% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 276,591 | $3,361,000 | 0.42% |
| MYDA Advisors LLC | 55,000 | $668,000 | 0.26% |
| Atom Investors LP | 40,855 | $496,000 | 0.23% |